Evidence map›Paper›PMID 28645307›Full record

ArticleMicrobiome2017

Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis.

Rebecca Rogier, Thomas H A Ederveen, Jos Boekhorst, Harm Wopereis, Jose U Scher, Julia Manasson, Sanne J C M Frambach, Jan Knol, Johan Garssen, Peter M van der Kraan and 4 more

Open access · goldAbstract read
In one paragraph

Article in Microbiome, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 95 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. [EJNMMI research · 2023
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. The role of the microbiome in rheumatoid arthritis: a review.Rheumatology advances in practice · 2023
    Review
  18. Review
  19. Review
  20. Mouse Models of Psoriasis: A Comprehensive Review.The Journal of investigative dermatology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Rebecca RogierExperimental Rheumatology (272), Radboud University Medical Center, PO Box 9101, 6500HB, Nijmegen, The Netherlands.
Thomas H A EderveenExperimental Rheumatology (272), Radboud University Medical Center, PO Box 9101, 6500HB, Nijmegen, The Netherlands.
Jos BoekhorstCentre for Molecular and Biomolecular Informatics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Harm WopereisDanone Nutricia Research, Utrecht, The Netherlands.
Jose U ScherDivision of Rheumatology, Department of Medicine, New York University School of Medicine, 301 East 17th Street, Room 1611A, New York, USA.
Julia ManassonDivision of Rheumatology, Department of Medicine, New York University School of Medicine, 301 East 17th Street, Room 1611A, New York, USA.
Sanne J C M FrambachExperimental Rheumatology (272), Radboud University Medical Center, PO Box 9101, 6500HB, Nijmegen, The Netherlands.
Jan KnolDanone Nutricia Research, Utrecht, The Netherlands.
Johan GarssenDanone Nutricia Research, Utrecht, The Netherlands.
Peter M van der KraanExperimental Rheumatology (272), Radboud University Medical Center, PO Box 9101, 6500HB, Nijmegen, The Netherlands.
Marije I KoendersExperimental Rheumatology (272), Radboud University Medical Center, PO Box 9101, 6500HB, Nijmegen, The Netherlands.
Wim B van den BergExperimental Rheumatology (272), Radboud University Medical Center, PO Box 9101, 6500HB, Nijmegen, The Netherlands.
Sacha A F T van HijumCentre for Molecular and Biomolecular Informatics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Shahla Abdollahi-RoodsazExperimental Rheumatology (272), Radboud University Medical Center, PO Box 9101, 6500HB, Nijmegen, The Netherlands. Shahla.Abdollahi-Roodsaz@radboudumc.nl.
Radboud University Medical Center · NLNew York University · USRadboud University Nijmegen · NLDanone (Netherlands) · NLDanone Nutricia Research (Netherlands)Utrecht University · NL

Funding

Translational Basic and Clinical Research Training in RheumatologyT32AR069515 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Jill P Buyon, Jose U. Scher · 2017 to 2026
$2.9M
NIAMS NIH HHS T32 AR069515
6 · The paper itself

Abstract

backgroundPerturbation of commensal intestinal microbiota has been associated with several autoimmune diseases. Mice deficient in interleukin-1 receptor antagonist (Il1rn

resultsUsing high-throughput 16S rRNA gene sequencing, we show that IL-1Ra critically maintains the diversity and regulates the composition of intestinal microbiota in mice. IL-1Ra deficiency reduced the intestinal microbial diversity and richness, and caused specific taxonomic alterations characterized by overrepresented Helicobacter and underrepresented Ruminococcus and Prevotella. Notably, the aberrant intestinal microbiota in IL1rn

conclusionsThese findings identify a critical role for IL1Ra in maintaining the natural diversity and composition of intestinal microbiota, and suggest a role for TLR4 in mucosal Th17 cell induction associated with the development of autoimmune disease in mice.

Indexed as

Gastrointestinal MicrobiomeAnimalsAnti-Bacterial AgentsArthritisAutoimmune DiseasesGenetic VariationHelicobacterHereditary Autoinflammatory DiseasesHigh-Throughput Nucleotide SequencingInterleukin-17Interleukin 1 Receptor Antagonist ProteinIntestinal MucosaMiceMice, KnockoutMucous MembranePrevotellaAnti-Bacterial AgentsInterleukin-17Interleukin 1 Receptor Antagonist ProteinRNA, Ribosomal, 16SToll-Like Receptor 4Autoimmune arthritisIL-1 receptor antagonistMicrobiotaT helper 17 cellsToll-like receptors

Identifiers

PMID28645307
PMCPMC5481968
OpenAlexW2634993714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.